• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

胚胎成纤维细胞和胸腺细胞中转化生长因子β受体I信号活性的调节不需要FKBP12。

FKBP12 is not required for the modulation of transforming growth factor beta receptor I signaling activity in embryonic fibroblasts and thymocytes.

作者信息

Bassing C H, Shou W, Muir S, Heitman J, Matzuk M M, Wang X F

机构信息

Department of Pharmacology & Cancer Biology, Duke University Medical Center, Durham, North Carolina 27710, USA.

出版信息

Cell Growth Differ. 1998 Mar;9(3):223-8.

PMID:9543388
Abstract

Transforming growth factor beta (TGF-beta) signals through a heteromeric complex of type I and type II transmembrane serine-threonine kinases. Recent evidence suggests that the immunophilin FKBP12 modulates the activity of the type I receptor, based on data that immunosuppressive drugs that disrupt FKBP12 binding to the type I receptor enhance TGF-beta signaling in mink lung epithelial cells, and overexpression of FKBP12 inhibits type I receptor phosphorylation by the type II receptor. To determine the physiological relevance of the FKBP12-TGF-beta receptor I interaction, we investigated whether disruption of this interaction affects TGF-beta-signaling in primary mouse embryo fibroblasts and thymocytes. We found that the addition of excess drugs had no effect on either TGF-beta-mediated transcriptional responses or growth inhibition. Dose-response curves for TGF-beta-mediated signaling in primary fibroblasts and thymocytes isolated from either wild-type or FKBP12-deficient mice were identical. Taken together, our results indicate that FKBP12 does not play a unique physiological role in TGF-beta signaling in primary fibroblasts and thymocytes.

摘要

转化生长因子β(TGF-β)通过I型和II型跨膜丝氨酸 - 苏氨酸激酶的异源复合物进行信号传导。最近的证据表明,免疫亲和素FKBP12调节I型受体的活性,这是基于以下数据:破坏FKBP12与I型受体结合的免疫抑制药物可增强水貂肺上皮细胞中的TGF-β信号传导,并且FKBP12的过表达会抑制II型受体对I型受体的磷酸化作用。为了确定FKBP12与TGF-β受体I相互作用的生理相关性,我们研究了这种相互作用的破坏是否会影响原代小鼠胚胎成纤维细胞和胸腺细胞中的TGF-β信号传导。我们发现添加过量药物对TGF-β介导的转录反应或生长抑制均无影响。从野生型或FKBP12缺陷型小鼠分离的原代成纤维细胞和胸腺细胞中,TGF-β介导的信号传导的剂量反应曲线是相同的。综上所述,我们的结果表明FKBP12在原代成纤维细胞和胸腺细胞的TGF-β信号传导中不发挥独特的生理作用。

相似文献

1
FKBP12 is not required for the modulation of transforming growth factor beta receptor I signaling activity in embryonic fibroblasts and thymocytes.胚胎成纤维细胞和胸腺细胞中转化生长因子β受体I信号活性的调节不需要FKBP12。
Cell Growth Differ. 1998 Mar;9(3):223-8.
2
The conventional transforming growth factor-beta (TGF-beta) receptor type I is not required for TGF-beta 1 signaling in a human prostate cancer cell line, LNCaP.在人前列腺癌细胞系LNCaP中,转化生长因子-β1(TGF-β1)信号传导并不需要传统的I型转化生长因子-β(TGF-β)受体。
Exp Cell Res. 1998 May 25;241(1):151-60. doi: 10.1006/excr.1998.4034.
3
Transforming growth factor-beta receptor expression on human skin fibroblasts: dimeric complex formation of type I and type II receptors and identification of glycosyl phosphatidylinositol-anchored transforming growth factor-beta binding proteins.人皮肤成纤维细胞上转化生长因子-β受体的表达:I型和II型受体的二聚体复合物形成以及糖基磷脂酰肌醇锚定的转化生长因子-β结合蛋白的鉴定
J Cell Physiol. 1998 Sep;176(3):553-64. doi: 10.1002/(SICI)1097-4652(199809)176:3<553::AID-JCP12>3.0.CO;2-0.
4
Gene expression profiling demonstrates that TGF-beta1 signals exclusively through receptor complexes involving Alk5 and identifies targets of TGF-beta signaling.基因表达谱分析表明,转化生长因子β1(TGF-β1)仅通过涉及激活素受体样激酶5(Alk5)的受体复合物进行信号传导,并确定了TGF-β信号传导的靶点。
Physiol Genomics. 2005 May 11;21(3):396-403. doi: 10.1152/physiolgenomics.00303.2004. Epub 2005 Mar 15.
5
Cardiac defects and altered ryanodine receptor function in mice lacking FKBP12.缺乏FKBP12的小鼠的心脏缺陷与兰尼碱受体功能改变
Nature. 1998 Jan 29;391(6666):489-92. doi: 10.1038/35146.
6
TGF-beta-signaling with small molecule FKBP12 antagonists that bind myristoylated FKBP12-TGF-beta type I receptor fusion proteins.使用与肉豆蔻酰化的FKBP12 - 转化生长因子β(TGF - β)I型受体融合蛋白结合的小分子FKBP12拮抗剂进行TGF - β信号传导。
Chem Biol. 1998 Jul;5(7):385-95. doi: 10.1016/s1074-5521(98)90072-2.
7
An emerging complexity of receptors for transforming growth factor-beta.转化生长因子-β受体中一个新出现的复杂性问题。
Princess Takamatsu Symp. 1994;24:264-75.
8
Modulation of transforming growth factor beta response and signaling during transdifferentiation of rat hepatic stellate cells to myofibroblasts.大鼠肝星状细胞向肌成纤维细胞转分化过程中转化生长因子β反应和信号传导的调节
Hepatology. 2000 May;31(5):1094-106. doi: 10.1053/he.2000.6126.
9
Lack of transforming growth factor-beta type II receptor expression in human retinoblastoma cells.人视网膜母细胞瘤细胞中转化生长因子-βⅡ型受体表达缺失。
J Cell Physiol. 1998 Jun;175(3):305-13. doi: 10.1002/(SICI)1097-4652(199806)175:3<305::AID-JCP8>3.0.CO;2-S.
10
Transforming growth factor beta signaling is disabled early in human endometrial carcinogenesis concomitant with loss of growth inhibition.转化生长因子β信号传导在人类子宫内膜癌发生早期即被破坏,同时伴随着生长抑制的丧失。
Cancer Res. 2002 May 15;62(10):2778-90.

引用本文的文献

1
Transforming growth factor-β signaling: from tumor microenvironment to anticancer therapy.转化生长因子-β信号传导:从肿瘤微环境到抗癌治疗
Explor Target Antitumor Ther. 2023;4(2):316-343. doi: 10.37349/etat.2023.00137. Epub 2023 Apr 28.
2
Transgenic analysis of the role of FKBP12.6 in cardiac function and intracellular calcium release.FKBP12.6在心脏功能和细胞内钙释放中作用的转基因分析
Assay Drug Dev Technol. 2011 Dec;9(6):620-7. doi: 10.1089/adt.2011.0411. Epub 2011 Nov 16.
3
Mammalian target of rapamycin inhibition as a therapeutic strategy in the management of urologic malignancies.
抑制哺乳动物雷帕霉素靶蛋白作为治疗泌尿生殖系统恶性肿瘤的一种治疗策略。
Mol Cancer Ther. 2008 Jun;7(6):1347-54. doi: 10.1158/1535-7163.MCT-07-2408.
4
TGF beta 1 inhibits Ca2+-calcineurin-mediated activation in thymocytes.转化生长因子β1抑制胸腺细胞中钙离子-钙调神经磷酸酶介导的激活。
J Immunol. 2003 Apr 1;170(7):3645-52. doi: 10.4049/jimmunol.170.7.3645.
5
FKBP12, the 12-kDa FK506-binding protein, is a physiologic regulator of the cell cycle.FKBP12,即12千道尔顿的FK506结合蛋白,是细胞周期的生理调节因子。
Proc Natl Acad Sci U S A. 2001 Feb 27;98(5):2425-30. doi: 10.1073/pnas.041614198. Epub 2001 Feb 20.
6
Hmo1p, a high mobility group 1/2 homolog, genetically and physically interacts with the yeast FKBP12 prolyl isomerase.Hmo1p是一种高迁移率族蛋白1/2同源物,在基因和物理层面上与酵母FKBP12脯氨酰异构酶相互作用。
Genetics. 1999 Mar;151(3):935-44. doi: 10.1093/genetics/151.3.935.